These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9152148)

  • 1. Unperceived visual field defects.
    Safran AB
    Arch Ophthalmol; 1997 May; 115(5):686-7. PubMed ID: 9152148
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group.
    Wu AW; Coleson LC; Holbrook J; Jabs DA
    Arch Ophthalmol; 1996 Jul; 114(7):841-7. PubMed ID: 8660168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group. AIDS Clinical Trials Group.
    Arch Ophthalmol; 1997 Dec; 115(12):1528-36. PubMed ID: 9400786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis.
    Martin BK; Kaplan Gilpin AM; Jabs DA; Wu AW;
    J Clin Epidemiol; 2001 Apr; 54(4):376-86. PubMed ID: 11305288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field constriction with relatively preserved central vision: an unusual case of early-onset retinal dystrophy.
    Heng S; McCulloch DL; Dutton GN
    J Pediatr Ophthalmol Strabismus; 2011 Aug; 48 Online():e52-4. PubMed ID: 21838212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the vision-specific quality of life using clustered visual field in glaucoma patients.
    Sawada H; Yoshino T; Fukuchi T; Abe H
    J Glaucoma; 2014 Feb; 23(2):81-7. PubMed ID: 22828009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group.
    Freeman WR; Van Natta ML; Jabs D; Sample PA; Sadun AA; Thorne J; Shah KH; Holland GN;
    Am J Ophthalmol; 2008 Mar; 145(3):453-462. PubMed ID: 18191094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual prognosis of AIDS patients with cytomegalovirus retinitis.
    Bloom PA; Sandy CJ; Migdal CS; Stanbury R; Graham EM
    Eye (Lond); 1995; 9 ( Pt 6)():697-702. PubMed ID: 8849536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Visual Field Clusters on Performance-based Measures and Vision-Related Quality of Life in Patients With Glaucoma.
    Sun Y; Lin C; Waisbourd M; Ekici F; Erdem E; Wizov SS; Hark LA; Spaeth GL
    Am J Ophthalmol; 2016 Mar; 163():45-52. PubMed ID: 26701273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular manifestations of AIDS.
    Whitcup SM
    JAMA; 1996 Jan; 275(2):142-4. PubMed ID: 8531310
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):787-93. PubMed ID: 17210182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field loss in CMV retinitis.
    Dreyer EB
    Ophthalmology; 1993 Feb; 100(2):148-9. PubMed ID: 8382352
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinician versus reading center assessment of cytomegalovirus retinitis lesion size.
    Weinberg DV; Holbrook JT; Hubbard LD; Davis MD; Jabs DA; Holland GN;
    Ophthalmology; 2005 Apr; 112(4):559-66. PubMed ID: 15808244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between Vision-related Quality of Life and Visual Function in Glaucoma Patients.
    Hirooka K; Sato S; Nitta E; Tsujikawa A
    J Glaucoma; 2016 Jun; 25(6):505-9. PubMed ID: 26766401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased visual acuity in patients with cytomegalovirus retinitis and AIDS.
    Raina J; Bainbridge JW; Shah SM
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():8-12. PubMed ID: 10755092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
    Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
    Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual field changes following implantation of the Argus II retinal prosthesis.
    Rizzo S; Belting C; Cinelli L; Allegrini L
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):323-5. PubMed ID: 25432093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.